On Monday, Argenx released positive clinical trial data from its proof-of-concept trial for its rare disease drug, efgartigimoid (ARGX-113).
The post Argenx Releases Positive Trial Results appeared first on Investing News Network.
Original Article: Argenx Releases Positive Trial Results
NEXT ARTICLE